HopeStage
Back to all studies
RecruitingNCT05299749

fMRI brain feedback for voices that persist despite treatment in schizophrenia

About this titleRead the official source — NCT05299749
Interventional studyAges 18–55United States
The study in practice

Understand this study

Who could participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria apply.

Listed locations
BrocktonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 1, 2022
Recruitment status
Recruiting
Enrollment listed in the registry
104
Sponsor
Boston VA Research Institute, Inc.
Sponsor type
Research institute
Study type
Other
Intervention type
Other
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT05299749
Official title
Show the full official title

Real-time fMRI Neurofeedback as a Tool to Mitigate Auditory Hallucinations in Patients With Schizophrenia - R33 Phase

Recruitment & locations

Currently recruiting

Brockton

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Boston VA Research Institute, Inc., a research institute.

Who can participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies